ID   STA5A_RAT               Reviewed;         793 AA.
AC   Q62771;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 169.
DE   RecName: Full=Signal transducer and activator of transcription 5A;
DE   AltName: Full=Mammary gland factor;
GN   Name=Stat5a; Synonyms=Mgf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS STAT5A1 AND STAT5A2).
RC   TISSUE=Mammary gland;
RX   PubMed=8584036; DOI=10.1210/mend.9.11.8584036;
RA   Kazansky A.V., Raught B., Lindsey S.M., Wang Y.-F., Rosen J.M.;
RT   "Regulation of mammary gland factor/Stat5a during mammary gland
RT   development.";
RL   Mol. Endocrinol. 9:1598-1609(1995).
RN   [2]
RP   FUNCTION, AND PHOSPHORYLATION AT TYR-694 IN RESPONSE TO CONSTITUTIVELY
RP   ACTIVATED FGFR3.
RX   PubMed=19088846; DOI=10.1371/journal.pone.0003961;
RA   Krejci P., Salazar L., Kashiwada T.A., Chlebova K., Salasova A.,
RA   Thompson L.M., Bryja V., Kozubik A., Wilcox W.R.;
RT   "Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal
RT   dysplasia undermines dominant role of STAT1 in FGFR3 signaling in
RT   cartilage.";
RL   PLoS ONE 3:E3961-E3961(2008).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-694 AND SER-779, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Carries out a dual function: signal transduction and
CC       activation of transcription. Mediates cellular responses to the
CC       cytokine KITLG/SCF and other growth factors. May mediate cellular
CC       responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the GAS
CC       element and activates PRL-induced transcription. Regulates the
CC       expression of milk proteins during lactation.
CC       {ECO:0000269|PubMed:19088846}.
CC   -!- SUBUNIT: Forms a homodimer or a heterodimer with a related family
CC       member. Binds NR3C1. Interacts with NCOA1 and SOCS7. Interacts with
CC       ERBB4 (By similarity). Interacts with EBF4. {ECO:0000250,
CC       ECO:0000250|UniProtKB:P42229}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Mostly cytoplasmic during pregnancy, whereas it becomes
CC       predominantly nuclear during early lactation. It is translocated into
CC       the nucleus in response to phosphorylation (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Stat5A1;
CC         IsoId=Q62771-1; Sequence=Displayed;
CC       Name=Stat5A2;
CC         IsoId=Q62771-2; Sequence=VSP_006288, VSP_006289;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, lung, and weakly in muscle.
CC   -!- DEVELOPMENTAL STAGE: Detected both in virgin rats and after mammary
CC       gland involution. The level of STAT5A increases constantly during
CC       pregnancy, but decreases at the onset of lactation and remains lows
CC       throughout lactation.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P42230}.
CC   -!- PTM: Tyrosine phosphorylated in response to KITLG/SCF, IL2, IL3, IL7,
CC       IL15, CSF2/GMCSF, GH1, PRL, EPO and THPO (By similarity). Activated KIT
CC       promotes phosphorylation on tyrosine residues and subsequent
CC       translocation to the nucleus (By similarity). Tyrosine phosphorylated
CC       in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4
CC       (PubMed:22673903). Tyrosine phosphorylation is required for DNA-binding
CC       activity and dimerization. Serine phosphorylation is also required for
CC       maximal transcriptional activity (By similarity). Tyrosine
CC       phosphorylated in response to signaling via activated FLT3; wild-type
CC       FLT3 results in much weaker phosphorylation than constitutively
CC       activated mutant FLT3. Alternatively, can be phosphorylated by JAK2 at
CC       Tyr-694 (By similarity). {ECO:0000250|UniProtKB:P40763,
CC       ECO:0000250|UniProtKB:P42229, ECO:0000250|UniProtKB:P42230}.
CC   -!- SIMILARITY: Belongs to the transcription factor STAT family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24175; AAA98843.1; -; mRNA.
DR   RefSeq; NP_058760.1; NM_017064.1.
DR   AlphaFoldDB; Q62771; -.
DR   SMR; Q62771; -.
DR   BioGRID; 247025; 3.
DR   STRING; 10116.ENSRNOP00000026662; -.
DR   GlyGen; Q62771; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62771; -.
DR   PhosphoSitePlus; Q62771; -.
DR   jPOST; Q62771; -.
DR   PaxDb; 10116-ENSRNOP00000026662; -.
DR   GeneID; 24918; -.
DR   KEGG; rno:24918; -.
DR   UCSC; RGD:3773; rat. [Q62771-1]
DR   AGR; RGD:3773; -.
DR   CTD; 6776; -.
DR   RGD; 3773; Stat5a.
DR   eggNOG; KOG3667; Eukaryota.
DR   InParanoid; Q62771; -.
DR   OrthoDB; 7823at2759; -.
DR   Reactome; R-RNO-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-RNO-1266695; Interleukin-7 signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-186763; Downstream signal transduction.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-8854691; Interleukin-20 family signaling.
DR   Reactome; R-RNO-8983432; Interleukin-15 signaling.
DR   Reactome; R-RNO-8985947; Interleukin-9 signaling.
DR   Reactome; R-RNO-9020558; Interleukin-2 signaling.
DR   Reactome; R-RNO-9020958; Interleukin-21 signaling.
DR   Reactome; R-RNO-982772; Growth hormone receptor signaling.
DR   PRO; PR:Q62771; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0042301; F:phosphate ion binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0050798; P:activated T cell proliferation; ISO:RGD.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IDA:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:MGI.
DR   GO; GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0006952; P:defense response; IBA:GO_Central.
DR   GO; GO:0046543; P:development of secondary female sexual characteristics; ISO:RGD.
DR   GO; GO:0046544; P:development of secondary male sexual characteristics; ISO:RGD.
DR   GO; GO:0030222; P:eosinophil differentiation; ISO:RGD.
DR   GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; ISO:RGD.
DR   GO; GO:0042492; P:gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0060397; P:growth hormone receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038156; P:interleukin-3-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0035771; P:interleukin-4-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038043; P:interleukin-5-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038113; P:interleukin-9-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0019915; P:lipid storage; ISO:RGD.
DR   GO; GO:0001553; P:luteinization; ISO:RGD.
DR   GO; GO:0030098; P:lymphocyte differentiation; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0061180; P:mammary gland epithelium development; ISO:RGD.
DR   GO; GO:0060056; P:mammary gland involution; IDA:RGD.
DR   GO; GO:0033024; P:mast cell apoptotic process; ISO:RGD.
DR   GO; GO:0060374; P:mast cell differentiation; ISO:RGD.
DR   GO; GO:0070662; P:mast cell proliferation; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; ISO:RGD.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0045647; P:negative regulation of erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0033026; P:negative regulation of mast cell apoptotic process; ISO:RGD.
DR   GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0048541; P:Peyer's patch development; ISO:RGD.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; ISO:RGD.
DR   GO; GO:0045579; P:positive regulation of B cell differentiation; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0045621; P:positive regulation of lymphocyte differentiation; ISO:RGD.
DR   GO; GO:0060376; P:positive regulation of mast cell differentiation; ISO:RGD.
DR   GO; GO:0070668; P:positive regulation of mast cell proliferation; ISO:RGD.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0032825; P:positive regulation of natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
DR   GO; GO:0038026; P:reelin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:RGD.
DR   GO; GO:0030856; P:regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0019218; P:regulation of steroid metabolic process; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; ISO:RGD.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0019530; P:taurine metabolic process; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IDA:RGD.
DR   CDD; cd10421; SH2_STAT5a; 1.
DR   CDD; cd16855; STAT5_CCD; 1.
DR   CDD; cd16849; STAT5_DBD; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 1.20.1050.20; STAT transcription factor, all-alpha domain; 1.
DR   Gene3D; 2.60.40.630; STAT transcription factor, DNA-binding domain; 1.
DR   Gene3D; 1.10.532.10; STAT transcription factor, N-terminal domain; 1.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd_sf.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR001217; STAT.
DR   InterPro; IPR046994; STAT5_CCD.
DR   InterPro; IPR035858; STAT5a/5b_DBD.
DR   InterPro; IPR048988; STAT_linker.
DR   InterPro; IPR036535; STAT_N_sf.
DR   InterPro; IPR013800; STAT_TF_alpha.
DR   InterPro; IPR015988; STAT_TF_coiled-coil.
DR   InterPro; IPR013801; STAT_TF_DNA-bd.
DR   InterPro; IPR012345; STAT_TF_DNA-bd_N.
DR   InterPro; IPR013799; STAT_TF_prot_interaction.
DR   PANTHER; PTHR11801; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; 1.
DR   PANTHER; PTHR11801:SF47; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF01017; STAT_alpha; 1.
DR   Pfam; PF02864; STAT_bind; 1.
DR   Pfam; PF02865; STAT_int; 1.
DR   Pfam; PF21354; STAT_linker; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00964; STAT_int; 1.
DR   SUPFAM; SSF49417; p53-like transcription factors; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   SUPFAM; SSF47655; STAT; 1.
DR   SUPFAM; SSF48092; Transcription factor STAT-4 N-domain; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cytoplasm; DNA-binding; Lactation;
KW   Nucleus; Phosphoprotein; Reference proteome; SH2 domain; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..793
FT                   /note="Signal transducer and activator of transcription 5A"
FT                   /id="PRO_0000182426"
FT   DOMAIN          589..686
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   REGION          772..793
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         90
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P42229"
FT   MOD_RES         128
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42229"
FT   MOD_RES         682
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P42229"
FT   MOD_RES         694
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000269|PubMed:19088846,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         779
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         740
FT                   /note="N -> K (in isoform Stat5A2)"
FT                   /evidence="ECO:0000303|PubMed:8584036"
FT                   /id="VSP_006288"
FT   VAR_SEQ         741..793
FT                   /note="Missing (in isoform Stat5A2)"
FT                   /evidence="ECO:0000303|PubMed:8584036"
FT                   /id="VSP_006289"
SQ   SEQUENCE   793 AA;  90833 MW;  C0C34EE3F5879FB5 CRC64;
     MAGWIQAQQL QGDALRQMQV LYGQHFPIEV RHYLAQWIES QPWDAIDLDN PQDRGQATQL
     LEGLVQELQK KAEHQVGEDG FVLKIKLGHY ATQLQNTYDR CPMELVRCIR HILYNEQRLV
     REANNCSSPA GVLVDAMSQK HLQINQTFEE LRLITQDTES ELKKLQQTQE YFIIQYQESL
     RIQAQFGQLA QLNPQERMSR ETALQQKQVS LETWLQREAQ TLQQYRVELV EKHQKTLQLL
     RKQQTIILDD ELIQWKRGQQ LAGNGGPPEG SLDVLQSWCE KLAEIIWQNR QQIRRAEHLC
     QQLPIPGPVE EMLAEVNATI TDIISALVTS TFIIEKQPPQ VLKTQTKFAA TVRLLVGGKL
     NVHMNPPQVK ATIISEQQAK SLLKNENTRN DYSGEILNNC CVMEYHQATG TLSAHFRNMS
     LKRIKRADRR GAESVTEEKF TVLFESQFSV GSNELVFQVK TLSLPVVVIV HGSQDHNATA
     TVLWDNAFAE PGRVPFAVPD KVLWPQLCEA LNMKFKAEVQ SNRGLTKENL VFLAQKLFNR
     RSNHLEDYNS MSVSWSQFNR ENLPGWNYTF WQWFDGVMEV LKKHHKPHWN DGAILGFVNK
     QQAHDLLINK PDGTFLLRFS DSEIGGITIA WKFDSPDRNL WNLKPFTTRD FSIRSLADRL
     GDLNYLIYVF PDRPKDEVFA KYYTPVLAKA VDGYVKPQIK QVVPEFVNAS ADAGANATYM
     DQAPSPVVCP QAHYNMYPPN PDPVLDQDGE FDLDETMDVA RHVEELLRRP MDSLDPRLSP
     PAGLFTSARS SLS
//
